Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
—1,100.571,098.941,103.801,084.24——
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
—605.15605.15606.69602.76——
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
—1,195.191,204.711,221.691,204.71——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
—1,739.911,734.501,734.501,710.67——
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
—638.56640.21645.32638.69——
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
—831.57840.48844.16834.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
—213.36213.36215.79212.77——
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
—3,234.183,171.863,195.363,145.46——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
—935.65937.31941.44933.16——
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
—1,449.261,454.771,462.651,447.95——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
—2,382.452,371.192,380.452,362.86——
IKT:NASDAQ
Inhibikase Therapeutics Inc
$1.88
-0.53%
(-0.0100) 1D
$1.88
0.00% (0.00)
Pre-market
Closed: Apr 28, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IKT...
Open
$1.88
High
$1.90
Low
$1.84
Mkt. cap
248.22M
Avg. vol.
1.52M
Volume
0.00
52-wk high
$2.36
52-wk low
$1.33
EPS
-$0.49
Beta
0.86
Shares outstanding
132.03M
No. of employees
35
News stories
From sources across the web
About Inhibikase Therapeutics Inc
CEO-
Employees35
Founded2008
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteinhibikase.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
10.51M
5.27M
7.65M
-23.43M
Cost of revenue
10.51M
5.27M
7.65M
-23.43M
Research and development expenses
-
-
-
22.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.25M
5.92M
5.61M
6.77M
Operating expense
5.25M
5.56M
5.61M
29.17M
Total operating expenses
15.76M
10.83M
13.26M
5.73M
Operating income
-15.76M
-10.83M
-13.26M
-5.73M
Other non operating income
-
-
-
-
EBT including unusual items
-13.68M
-9.92M
-11.93M
-12.73M
EBT excluding unusual items
-14.84M
-9.92M
-12.42M
-4.69M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-358.42K
-
-
Net income
-13.68M
-9.92M
-11.93M
-12.73M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
919.27K
916.76K
838.09K
1.04M
Interest expense
-
-
-
-
Net interest expenses
919.27K
916.76K
838.09K
1.04M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.75M
-10.81M
-13.24M
-5.73M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer